[go: up one dir, main page]

CA2365917A1 - Proteines morphogeniques osseuses bmp - Google Patents

Proteines morphogeniques osseuses bmp Download PDF

Info

Publication number
CA2365917A1
CA2365917A1 CA002365917A CA2365917A CA2365917A1 CA 2365917 A1 CA2365917 A1 CA 2365917A1 CA 002365917 A CA002365917 A CA 002365917A CA 2365917 A CA2365917 A CA 2365917A CA 2365917 A1 CA2365917 A1 CA 2365917A1
Authority
CA
Canada
Prior art keywords
polypeptide
sequence
seq
polypeptides
polynucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002365917A
Other languages
English (en)
Inventor
Steven M. Ruben
Jian Ni
George Komatsoulis
Craig A. Rosen
Yanggu Shi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2365917A1 publication Critical patent/CA2365917A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurosurgery (AREA)

Abstract

L'invention concerne des nouveaux polypeptides BMP humains et des acides nucléiques contenant les régions codantes des gène codant pour lesdits polypeptides. Elle porte également sur des vecteurs, sur des cellules hôtes, sur des anticorps et sur des méthodes de recombinaison pour la production de polypeptides BMP humains. Elle se rapporte encore à des méthodes diagnostiques et thérapeutiques utiles pour le diagnostic et le traitement de troubles liés à ces nouveaux polypeptides BMP humains.
CA002365917A 1999-04-09 2000-04-06 Proteines morphogeniques osseuses bmp Abandoned CA2365917A1 (fr)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US12870199P 1999-04-09 1999-04-09
US60/128,701 1999-04-09
US13069399P 1999-04-23 1999-04-23
US60/130,693 1999-04-23
US13167299P 1999-04-29 1999-04-29
US60/131,672 1999-04-29
US13863299P 1999-06-11 1999-06-11
US60/138,632 1999-06-11
US14702099P 1999-08-03 1999-08-03
US60/147,020 1999-08-03
US15293399P 1999-09-09 1999-09-09
US60/152,933 1999-09-09
PCT/US2000/009028 WO2000061774A2 (fr) 1999-04-09 2000-04-06 Proteines morphogeniques osseuses bmp

Publications (1)

Publication Number Publication Date
CA2365917A1 true CA2365917A1 (fr) 2000-10-19

Family

ID=27558086

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002365917A Abandoned CA2365917A1 (fr) 1999-04-09 2000-04-06 Proteines morphogeniques osseuses bmp

Country Status (4)

Country Link
JP (1) JP2003527076A (fr)
AU (1) AU4073600A (fr)
CA (1) CA2365917A1 (fr)
WO (1) WO2000061774A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003527076A (ja) * 1999-04-09 2003-09-16 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド 骨形態形成タンパク質
AU2001265162A1 (en) * 2000-05-26 2001-12-11 Millennium Pharmaceuticals, Inc. 47765, a novel human lysyl oxidase and uses thereof
US7208300B2 (en) 2000-08-08 2007-04-24 Wyeth Member of the lysyl oxidase gene family
WO2002039118A1 (fr) * 2000-11-06 2002-05-16 Thrasos, Inc. Procedes de criblage de mimetiques morphogenetiques osseux
JP2002272470A (ja) * 2001-03-21 2002-09-24 Takashi Nakamura リジルオキシダーゼ関連タンパク質をコードする核酸
BR0213738A (pt) 2001-10-31 2006-11-21 Alcon Inc proteìnas morfogênicas ósseas (bmp), receptores de bmp e proteìnas de ligação de bmp e seu uso no diagnóstico e no tratamento de glaucoma
EP1777519A1 (fr) * 2001-10-31 2007-04-25 Alcon, Inc. Protéines morphogeniques osseuses (BMP), recepteurs desdites protéines et protéines de liaison de ces protéines, et leur utilisation pour le diagnostic et le traitement du glaucome
CA2480554A1 (fr) * 2002-03-28 2003-10-09 Tissuegene, Inc. Generation d'os par therapie genique
CN112574293B (zh) * 2020-12-11 2022-12-16 浙江万里学院 一种利用超声辅助从鳖背甲中脱钙提取胶原蛋白的工艺

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5716834A (en) * 1994-08-19 1998-02-10 National University Of Singapore Cloned factor C cDNA of the Singapore horseshoe crab, Carcinoscorpius rotundicauda and purification of factor C proenzyme
US6054293A (en) * 1997-07-08 2000-04-25 The Regents Of The University Of California Semaphorin receptors
JP2003527076A (ja) * 1999-04-09 2003-09-16 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド 骨形態形成タンパク質

Also Published As

Publication number Publication date
WO2000061774A3 (fr) 2004-12-29
AU4073600A (en) 2000-11-14
WO2000061774A2 (fr) 2000-10-19
JP2003527076A (ja) 2003-09-16

Similar Documents

Publication Publication Date Title
CA2390465A1 (fr) Polynucleotides inhibiteurs de protease du type de kunitz, polypeptides et anticorps
CA2398255A1 (fr) Polynucleotides semblables a bcl-2, polypeptides et anticorps
CA2385703A1 (fr) Polynucleotides semblables a plasminogene, polypeptides et anticorps
CA2373638A1 (fr) Polynucleotides et polypeptides adam
EP1179052A2 (fr) Serine proteases
CA2382018A1 (fr) Polynucleotides, polypeptides et anticorps interagissant avec les recepteurs de retinoides
CA2385487A1 (fr) 13 proteines associees au cancer du colon et au colon humain
EP1345567A2 (fr) Polynucleotides, polypeptides et anticorps de transport de canaux calciques
CA2381451A1 (fr) Anticorps, polypeptides polynucleotides apparentes a l'attractine
WO2000052160A1 (fr) Proteines serpines humaines
CA2365917A1 (fr) Proteines morphogeniques osseuses bmp
EP1206491A1 (fr) Polynucleotides, polypeptides du recepteur du tgf-beta et anticorps
WO2000061614A2 (fr) Proteines bruleuses de graisses excedentaires
CA2373693A1 (fr) Genes recepteurs heptatransmembranaires
WO2000070076A1 (fr) Recepteurs tm4sf
CA2392693A1 (fr) Quatre polynucleotides contenant un domaine noyau de disulfure (fdcd), polypeptides, et anticorps
CA2396591A1 (fr) Polynucleotides, polypeptides de transport de cassette de fixation de l'adenosine triphosphate (abc) et anticorps
CA2378929A1 (fr) Serine proteases
EP1214342A1 (fr) Polynecluotides, polypeptides et anticorps de recepteurs a hormones steroides
EP1233777A1 (fr) Anticorps, polypeptides et polynucleotides de type mip (proteine intrinseque majeure)
WO2001098476A1 (fr) Polynucleotides codant les serine proteases humaines

Legal Events

Date Code Title Description
FZDE Dead